| abstract |
A method of diagnosing, prognosing, and monitoring ovarian cancer in a subject by detecting hK10 in a sample, preferably a serum sample or a tumor tissue extract, from the subject. hK10 can be measured using a reagent that detects or binds to hK10, preferably an antibody that is specifically reactive with hK10 or a portion thereof. Methods for imaging tumors associated with hK10 using a reagent that binds to hK10 with a label for tumor imaging are also described. |